Pharma Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Beth Israel Deaconess Hospital, Boston, U.S.
Researchers from the United States publish new studies and findings in the area of apoptosis
July 4th, 2006
New findings from the United States describe advances in apoptosis. Study 1: According to research from the United States, apoptosis of activated CD4+ and CD8+ T cells is enhanced by co-culture with hepatocytes expressing hepatitis C virus (HCV) structural proteins through FasL induction. "A central unresolved issue in HCV infection is how the virus establishes chronic infection. Recent studies suggest that the liver microenvironment leads to apoptosis of activated T cells, which may be involved in the tolerance to liver allograft," wrote K. Iken and colleagues, Beth Israel Deaconess Hospital. "Here, we report that murine hepatocytes expressing a...
Source: Pharma Law Weekly (2006-07-04)
|
